RA CAPITAL MANAGEMENT, L.P.'s Net Worth
Estimate Recalculated Dec 3, 2025 07:31PM EST
Who is RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. has an estimated net worth of $26.8 Million. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., Dicerna Pharmaceuticals Inc, Eidos Therapeutics, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., PMV Pharmaceuticals, Inc., Nkarta, Inc., DICE Therapeutics, Inc., SANGAMO BIOSCIENCES INC, Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., Inhibrx, Inc., RxSight, Inc., Phathom Pharmaceuticals, Inc., Dyne Therapeutics, Inc., TG THERAPEUTICS, INC., Aclaris Therapeutics, Inc., Eiger BioPharmaceuticals, Inc., Eliem Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Forma Therapeutics Holdings, Inc.,, Therapeutics Acquisition Corp., G1 Therapeutics, Inc., ARVINAS INC., Synthorx, Inc., CURIS INC, Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Inozyme Pharma, Inc., Pandion Therapeutics Holdco LLC, Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, scPharmaceuticals Inc., Satsuma Pharmaceuticals, Inc., Akouos, Inc., Cardiff Oncology, Inc., Wave Life Sciences Ltd., Werewolf Therapeutics, Inc., IMARA Inc., Ra Pharmaceuticals, Inc., Fulcrum Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, ARS Pharmaceuticals, Inc., PepGen Inc., Black Diamond Therapeutics, Inc., DERMA SCIENCES, INC., SEQUENOM INC, BIOSPECIFICS TECHNOLOGIES CORP, Acrivon Therapeutics, Inc., ARADIGM CORP, LIPID SCIENCES INC/, LENZ Therapeutics, Inc., Boundless Bio, Inc., Cidara Therapeutics, Inc., and Artiva Biotherapeutics, Inc..
SEC CIK
RA CAPITAL MANAGEMENT, L.P.'s CIK is 0001346824
Past Insider Trading and Trends
2014 was RA CAPITAL MANAGEMENT, L.P.'s most active year for acquiring shares with 42 total transactions. RA CAPITAL MANAGEMENT, L.P.'s most active month to acquire stocks was the month of February. 2014 was RA CAPITAL MANAGEMENT, L.P.'s most active year for disposing of shares, totalling 88 transactions. RA CAPITAL MANAGEMENT, L.P.'s most active month to dispose stocks was the month of June. 2014 saw RA CAPITAL MANAGEMENT, L.P. paying a total of $47,444,071.66 for 2,735,462 shares, this is the most they've acquired in one year. In 2014 RA CAPITAL MANAGEMENT, L.P. cashed out on 6,123,149 shares for a total of $72,513,944.18, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
